HighTower Advisors’s VanEck CLO ETF CLOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.37M Sell
44,772
-66,794
-60% -$3.53M ﹤0.01% 1669
2026
Q1
$5.88M Sell
111,566
-209,469
-65% -$11.1M 0.01% 1116
2025
Q4
$17M Buy
321,035
+6,703
+2% +$355K 0.02% 665
2025
Q3
$16.7M Buy
314,332
+12,619
+4% +$668K 0.02% 659
2025
Q2
$16M Buy
301,713
+40,678
+16% +$2.14M 0.02% 624
2025
Q1
$13.8M Buy
261,035
+29,728
+13% +$1.57M 0.02% 647
2024
Q4
$12.2M Buy
+231,307
New +$12.3M 0.02% 677

Other funds holding CLOI

HighTower Advisors's CLOI Position: Q2 2026 in Review

HighTower Advisors reduced its VanEck CLO ETF (CLOI) stake by 60% in Q2 2026, selling an estimated $3.53M and leaving 44,772 shares worth $2.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1669.

HighTower Advisors first reported a position in CLOI in Q4 2024 and has held it in 7 quarters since. The position peaked at $17M in Q4 2025. 198 funds tracked by Wall St. Rank hold CLOI as of Q2 2026.

  • HighTower Advisors held 44,772 shares of VanEck CLO ETF worth $2.37M as of Q2 2026.
  • HighTower Advisors sold 66,794 VanEck CLO ETF shares in Q2 2026, an estimated $3.53M.
  • VanEck CLO ETF made up ﹤0.01% of HighTower Advisors's portfolio in Q2 2026, its #1669 holding.
  • HighTower Advisors first reported a position in VanEck CLO ETF in Q4 2024 and has held it in 7 quarters since.
  • HighTower Advisors's VanEck CLO ETF position peaked at $17M in Q4 2025.
  • 198 funds tracked by Wall St. Rank held VanEck CLO ETF as of Q2 2026.

Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.